Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot study.

    Lipscomb ER, Finch EA, Brizendine E, Saha CK, Hays LM, Ackermann RT.

    Diabetes Care. 2009 Mar;32(3):394-6. Epub 2008 Dec 23.PMID: 19106377 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lifestyle intervention in overweight individuals with a family history of diabetes.

    Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W.

    Diabetes Care. 1998 Mar;21(3):350-9.PMID: 9540015 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study.

    Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG.

    Am J Prev Med. 2008 Oct;35(4):357-63.PMID: 18779029 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.

    Vestfold Heartcare Study Group.

    Eur J Cardiovasc Prev Rehabil. 2003 Dec;10(6):429-37.PMID: 14671465 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]

    Flórez H.

    Invest Clin. 1997 Mar;38(1):39-52. Review. Spanish. PMID: 9235072 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.

    Clifford RM, Davis WA, Batty KT, Davis TM; Fremantle Diabetes Study.

    Diabetes Care. 2005 Apr;28(4):771-6.PMID: 15793171 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial.

    Lindström J, Eriksson JG, Valle TT, Aunola S, Cepaitis Z, Hakumäki M, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Martikkala V, Moltchanov V, Rastas M, Salminen V, Sundvall J, Uusitupa M, Tuomilehto J.

    J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S108-13.PMID: 12819313 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

    Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group.

    N Engl J Med. 2001 May 3;344(18):1343-50.PMID: 11333990 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.

    Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH.

    Lancet. 2008 May 24;371(9626):1783-9.PMID: 18502303 [PubMed - indexed for MEDLINE]Related articles

    10.

    Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

    Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group.

    Lancet. 2006 Nov 11;368(9548):1673-9.PMID: 17098085 [PubMed - indexed for MEDLINE]Related articles

    11.

    Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.

    Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study (DPS) Group.

    Diabetes Care. 2008 May;31(5):857-62. Epub 2008 Feb 5.PMID: 18252900 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Lifestyle changes can be achieved through counseling and follow-up in first-degree relatives of patients with type 2 diabetes.

    Brekke HK, Jansson PA, Månsson JE, Lenner RA.

    J Am Diet Assoc. 2003 Jul;103(7):835-43.PMID: 12830021 [PubMed - indexed for MEDLINE]Related articles

    13.

    The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity.

    Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group.

    Diabetes Care. 2003 Dec;26(12):3230-6.PMID: 14633807 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report.

    Sone H, Katagiri A, Ishibashi S, Abe R, Saito Y, Murase T, Yamashita H, Yajima Y, Ito H, Ohashi Y, Akanuma Y, Yamada N; JD Study Group.

    Horm Metab Res. 2002 Sep;34(9):509-15.PMID: 12384828 [PubMed - indexed for MEDLINE]Related articles

    15.

    Development and piloting of a community health worker-based intervention for the prevention of diabetes among New Zealand Maori in Te Wai o Rona: Diabetes Prevention Strategy.

    Simmons D, Rush E, Crook N; Te Wai o Rona: Diabetes Prevention Strategy Team.

    Public Health Nutr. 2008 Dec;11(12):1318-25. Epub 2008 Jun 12.PMID: 18547452 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

    Kosaka K, Noda M, Kuzuya T.

    Diabetes Res Clin Pract. 2005 Feb;67(2):152-62.PMID: 15649575 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial.

    Maruthur NM, Wang NY, Appel LJ.

    Circulation. 2009 Apr 21;119(15):2026-31. Epub 2009 Apr 6.PMID: 19349322 [PubMed - indexed for MEDLINE]Related articles

    18.

    Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives.

    Scott A, Tinelli M, Bond C; Community Pharmacy Medicines Management Evaluation Team.

    Pharmacoeconomics. 2007;25(5):397-411.PMID: 17488138 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of a diabetes self-management program on glycemic control, coronary heart disease risk, and quality of life among Thai patients with type 2 diabetes.

    Wattana C, Srisuphan W, Pothiban L, Upchurch SL.

    Nurs Health Sci. 2007 Jun;9(2):135-41.PMID: 17470188 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

    Eddy DM, Schlessinger L, Kahn R.

    Ann Intern Med. 2005 Aug 16;143(4):251-64.PMID: 16103469 [PubMed - indexed for MEDLINE]Related articlesFree article